Trial Profile
Multi-centre, Open-label, Non-randomised Single Dose Trial Investigating the Pharmacokinetics of N8 in Japanese Subjects With Haemophilia A
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Feb 2017
Price :
$35
*
At a glance
- Drugs Turoctocog alfa (Primary)
- Indications Haemophilia A
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 27 Oct 2014 New trial record